Your browser doesn't support javascript.
loading
Incidence, risk factors, and feto-maternal outcomes of inappropriate birth weight for gestational age among singleton live births in Qatar: A population-based study.
Younes, Salma; Samara, Muthanna; Salama, Noor; Al-Jurf, Rana; Nasrallah, Gheyath; Al-Obaidly, Sawsan; Salama, Husam; Olukade, Tawa; Hammuda, Sara; Abdoh, Ghassan; Abdulrouf, Palli Valapila; Farrell, Thomas; AlQubaisi, Mai; Al Rifai, Hilal; Al-Dewik, Nader.
Afiliação
  • Younes S; Department of Research, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
  • Samara M; Department of Psychology, Kingston University London, Kingston upon Thames, United Kingdom.
  • Salama N; Health Profession Awareness Program, Health Facilities Development, Hamad Medical Corporation (HMC), Doha, Qatar.
  • Al-Jurf R; American University in Cairo (AUC), Cairo, Egypt.
  • Nasrallah G; College of Health and Life Science (CHLS), Hamad Bin Khalifa University (HBKU), Doha, Qatar.
  • Al-Obaidly S; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
  • Salama H; Obstetrics and Gynecology Department, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
  • Olukade T; Department of Pediatrics and Neonatology, Neonatal Intensive Care Unit, Newborn Screening Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
  • Hammuda S; Department of Pediatrics and Neonatology, Neonatal Intensive Care Unit, Newborn Screening Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
  • Abdoh G; Department of Psychology, Kingston University London, Kingston upon Thames, United Kingdom.
  • Abdulrouf PV; Department of Pediatrics and Neonatology, Neonatal Intensive Care Unit, Newborn Screening Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
  • Farrell T; Department of Research, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
  • AlQubaisi M; Department of Pharmacy, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
  • Al Rifai H; Department of Research, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
  • Al-Dewik N; Obstetrics and Gynecology Department, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
PLoS One ; 16(10): e0258967, 2021.
Article em En | MEDLINE | ID: mdl-34710154
BACKGROUND: Abnormal fetal growth can be associated with factors during pregnancy and at postpartum. OBJECTIVE: In this study, we aimed to assess the incidence, risk factors, and feto-maternal outcomes associated with small-for-gestational age (SGA) and large-for-gestational age (LGA) infants. METHODS: We performed a population-based retrospective study on 14,641 singleton live births registered in the PEARL-Peristat Study between April 2017 and March 2018 in Qatar. We estimated the incidence and examined the risk factors and outcomes using univariate and multivariate analysis. RESULTS: SGA and LGA incidence rates were 6.0% and 15.6%, respectively. In-hospital mortality among SGA and LGA infants was 2.5% and 0.3%, respectively, while for NICU admission or death in labor room and operation theatre was 28.9% and 14.9% respectively. Preterm babies were more likely to be born SGA (aRR, 2.31; 95% CI, 1.45-3.57) but male infants (aRR, 0.57; 95% CI, 0.4-0.81), those born to parous (aRR 0.66; 95% CI, 0.45-0.93), or overweight (aRR, 0.64; 95% CI, 0.42-0.97) mothers were less likely to be born SGA. On the other hand, males (aRR, 1.82; 95% CI, 1.49-2.19), infants born to parous mothers (aRR 2.16; 95% CI, 1.63-2.82), or to mothers with gestational diabetes mellitus (aRR 1.36; 95% CI, 1.11-1.66), or pre-gestational diabetes mellitus (aRR 2.58; 95% CI, 1.8-3.47) were significantly more likely to be LGA. SGA infants were at high risk of in-hospital mortality (aRR, 226.56; 95% CI, 3.47-318.22), neonatal intensive care unit admission or death in labor room or operation theatre (aRR, 2.14 (1.36-3.22). CONCLUSION: Monitoring should be coordinated to alleviate the risks of inappropriate fetal growth and the associated adverse consequences.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Macrossomia Fetal / Nascimento Prematuro Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Macrossomia Fetal / Nascimento Prematuro Idioma: En Ano de publicação: 2021 Tipo de documento: Article